Filing Details

Accession Number:
0000049071-12-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-29 13:00:00
Reporting Period:
2012-03-29
Filing Date:
2012-03-29
Accepted Time:
2012-03-29 17:26:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
49071 Humana Inc HUM Hospital & Medical Service Plans (6324) 610647538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1133713 H James Bloem Humana Inc.
500 West Main Street
Louisville KY 40202
Sr. Vp, Cfo & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Humana Common Acquisiton 2012-03-29 35,005 $62.10 78,575 No 4 M Direct
Humana Common Disposition 2012-03-29 35,005 $90.27 43,570 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Humana Common Options Disposition 2012-03-29 35,005 $62.10 35,005 $62.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-22 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Humana Common Options $69.48 2015-02-21 46,436 46,436 Direct
Humana Common Options $46.40 2017-02-18 12,118 12,118 Direct
Humana Common Options $61.18 2018-02-17 15,178 15,178 Direct
Humana Common Options $88.65 2019-02-23 28,436 28,436 Direct
Humana Common Restricted Stock Units $0.00 5,149 5,149 Direct
Humana Common Restricted Stock Units $0.00 17,201 17,201 Direct
Humana Common Restricted Stock Units $0.00 5,528 5,528 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-02-21 46,436 46,436 Direct
2017-02-18 12,118 12,118 Direct
2018-02-17 15,178 15,178 Direct
2019-02-23 28,436 28,436 Direct
5,149 5,149 Direct
17,201 17,201 Direct
5,528 5,528 Direct
Footnotes
  1. Right to buy pursuant to the Company's 2003 Stock Incentive Plan.
  2. Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.
  3. Incentive and Non-Qualified stock options granted to reporting person on 2/21/08, NQ options vesting in three increments from 2/21/09 to 2/21/11, and ISO's vesting on 2/21/11.
  4. Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/18/11 to 2/18/13.
  5. Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/17/12 to 2/17/14.
  6. Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/23/13 to 2/23/15.
  7. Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.
  8. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
  9. Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.
  10. Restricted stock units granted to reporting person on 11/7/11, 100% of the award is vesting on 11/7/13.
  11. Restricted stock units granted to reporting person on 2/23/12, 100% of the award is vesting on 2/23/15.
  12. This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $90.24 to $90.39. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.